Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta 
activity

Trivedi, Chinmay M.; Luo, Yang; Yin, Zhan; Zhang, Maozhen; Zhu, Wenting; Wang, Tao; Floss, Thomas; Goettlicher, Martin; Ruiz Noppinger, Patricia; Wurst, Wolfgang; Ferrari, Victor A.; Abrams, Charles S.; Gruber, Peter J.; Epstein, Jonathan A.

doi:doi:10.1038/nm1552

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity

MPS-Authors

Ruiz Noppinger, Patricia
Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Trivedi, C. M., Luo, Y., Yin, Z., Zhang, M., Zhu, W., Wang, T., et al. (2007). Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nature Medicine, 13(3), 324-331. doi:doi:10.1038/nm1552.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-8232-9

Abstract

In the adult heart, a variety of stresses induce re-expression of a fetal gene program in association with myocyte hypertrophy and heart failure. Here we show that histone deacetylase-2 (Hdac2) regulates expression of many fetal cardiac isoforms. Hdac2 deficiency or chemical histone deacetylase (HDAC) inhibition prevented the re-expression of fetal genes and attenuated cardiac hypertrophy in hearts exposed to hypertrophic stimuli. Resistance to hypertrophy was associated with increased expression of the gene encoding inositol polyphosphate-5-phosphatase f (Inpp5f) resulting in constitutive activation of glycogen synthase kinase 3beta (Gsk3beta) via inactivation of thymoma viral proto-oncogene (Akt) and 3-phosphoinositide-dependent protein kinase-1 (Pdk1). In contrast, Hdac2 transgenic mice had augmented hypertrophy associated with inactivated Gsk3beta. Chemical inhibition of activated Gsk3beta allowed Hdac2-deficient adults to become sensitive to hypertrophic stimulation. These results suggest that Hdac2 is an important molecular target of HDAC inhibitors in the heart and that Hdac2 and Gsk3beta are components of a regulatory pathway providing an attractive therapeutic target for the treatment of cardiac hypertrophy and heart failure.